Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: DIASORIN MOLECULAR, LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-12-01 to 2024-09-30
Current total value of award: $268184
Description: FUNDING MODIFICATION ACTION UNDER FAR 52.232-18.